Injured Patient Files New Internal Bleeding Lawsuit
A new internal bleeding lawsuit has been filed by a patient who alleges that the drug is responsible for severe internal bleeding that compromised her life.
According to the internal bleeding lawsuit, plaintiff Merl-Jane H. of Utah ingested between September of 2014 and November of 2015. On Nov. 11, 2015, she suffered severe internal bleeding and the internal bleeding lawsuit alleges this was directly tied to her ingestion of the medication. The lawsuit has been filed against Johnson and Johnson Research and Development, also known as Janssen R&D.
Unfortunately, this is not the first internal bleeding lawsuit of its kind. In fact, an increasing number of patients argue that the company knew about the dangerous risks and failed to disclose it to doctors. Those suffering from severe side effects have initiated lawsuits just like this.
is a relatively recent oral anticoagulant. The purpose of is to minimize the risk of systemic embolism and stroke in patients that have nonvalvular atrial fibrillation to reduce the recurrence of pulmonary embolism and deep vein thrombosis. In addition, is used to treat prophylaxis of deep vein thrombosis for those patients who have gone through knee and hip replacement surgery.
The internal bleeding lawsuit argues that the academic and medical research studies used to support the approval of the medication through the FDA were flawed and inaccurate.
has been advertised as an alternative to Warfarin, an anticoagulant that has been on the market for decades and has been shown to be relatively safe for patients affected by many of the same conditions for which is prescribed.
The internal bleeding lawsuit argues that the manufacturers are responsible for failing to study and define the safety profile of the medication, failing to disclose the need for dose adjustments that would have enabled doctors and patients to take the drug in a safer manner and failing to provide adequate warning regarding the difficulty of assessing the extent of anticoagulation in patients taking . Furthermore, there were no instructions provided about how to stabilize or intervene when a patient suffered severe internal bleeding while taking .
Accordingly, the lawsuit alleges that the manufacturers should be held responsible for the injuries sustained by the patient. If you or someone you know has been seriously injured in the form of internal bleeding after taking , you may have grounds to pursue an injury claim.
The lawyers at McDonald Worley are currently investigating claims brought forward by patients who may have suffered injuries because of . Call today, the case evaluation is free!